a 63162 has been researched along with calcimycin in 3 studies
Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
31 | 0 | 0 | 11,946 | 40 | 444 |
Protein | Taxonomy | a 63162 (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atluru, D; Atluru, S; Erickson, HH; McVey, DS; Olsen, SC | 1 |
Bailie, MB; Carter, GW; Dahm, LJ; Harris, RR; Peters-Golden, M; Roth, RA | 1 |
Atluru, D; Gudapaty, S; O'Donnell, MP; Woloschak, GE | 1 |
3 other study(ies) available for a 63162 and calcimycin
Article | Year |
---|---|
Inhibition of equine mononuclear cell proliferation and leukotriene B4 synthesis by a specific 5-lipoxygenase inhibitor, A-63162.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetamides; Animals; Calcimycin; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Horses; Indomethacin; Interleukin-2; Isoquinolines; Leukocytes, Mononuclear; Leukotriene B4; Lipoxygenase Inhibitors; Lymphocyte Activation; Phenyl Ethers; Phytohemagglutinins; Piperazines; Protein Kinase Inhibitors | 1992 |
Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
Topics: 1-Naphthylisothiocyanate; Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione; Hydroxyurea; Indoles; Inflammation; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Phenyl Ethers; Rats; Rats, Sprague-Dawley | 1995 |
Inhibition of human mononuclear cell proliferation, interleukin synthesis, mRNA for IL-2, IL-6, and leukotriene B4 synthesis by a lipoxygenase inhibitor.
Topics: Acetamides; Calcimycin; Cell Division; Cells, Cultured; Gene Expression; Humans; Interleukin-2; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Leukotriene B4; Lipoxygenase Inhibitors; Phenyl Ethers; Phytohemagglutinins; Receptors, Interleukin-2; RNA, Messenger; Tetradecanoylphorbol Acetate | 1993 |